Explore Cell Therapy
by National Marrow Donor Program/Be The Match
August 13, 2024 4:30 am
In Explore Cell Therapy, we dig into the latest cell and gene therapy research and best practices to help you advance care for patients with hematologic malignancies and disorders. You’ll hear interviews with well-known and up-and-coming physicians in the hematopoietic stem cell transplantation (HCT) and cell and gene therapy field. You’ll receive insights from the National Marrow Donor Program®/Be The Match® and our partners into what it takes to connect patients to the best available therapies. In season 2, we examine practice-changing research and hot topics in HCT and other cellular therapies. You’ll hear conversations with experts who specialize in HCT and at community hematology/oncology practices.
Recent Episodes
12 - Streamlining HCT Referrals, Part I: Overcoming Barriers through Coordinated Care
3 months ago12- Streamlining HCT Referrals, Part II: Assessing the Impact and Future State
3 months ago11 - First-line BMT for Severe Aplastic Anemia, Pt. 2: Future Research and Care Coordination
5 months ago11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity
5 months ago10 – Trends in HCT Equity, Access and Outcomes, Pt. 2: Personalization and Future Care
9 months ago10 – Trends in HCT Equity, Access and Outcomes, Pt. 1: Improvements and Challenges
9 months ago09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care
11 months ago09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes
12 months ago08 - Returning to Work Post-HCT, Pt. 2: Communication and Resources to Overcome Barriers
1 year ago08 – Returning to Work Post-HCT, Pt. 1: Guidance Development and Challenges
1 year ago